Edition:
United Kingdom

CellaVision AB (CEVI.ST)

CEVI.ST on Stockholm Stock Exchange

361.50SEK
5:00pm BST
Change (% chg)

8.50kr (+2.41%)
Prev Close
353.00kr
Open
358.00kr
Day's High
366.00kr
Day's Low
348.00kr
Volume
92,520
Avg. Vol
43,247
52-wk High
409.50kr
52-wk Low
185.00kr

Summary

Name Age Since Current Position

Soren Mellstig

68 2016 Independent Chairman of the Board

Zlatko Rihter

49 2015 President, Chief Executive Officer

Magnus Blixt

53 2015 Chief Financial Officer

Mattias Lundin

51 2015 Vice President Global Sales

Peter Wilson

52 Vice President Global Marketing

Maria Morin

45 2015 Vice President Human Resources & Corporate Communications

Magnus Johnsson

44 2016 Vice President Quality

Magnus Lindeberg

44 2016 Vice President Supply & Sourcing

Adam Morell

43 2015 Vice President Innovation & Engineering

Jeppe Brandstrup

45 2016 Vice President Business Development

Christer Fahraeus

54 1998 Director

Asa Hedin

57 2015 Independent Director

Anna Malm Bernsten

58 2010 Independent Director

Niklas Prager

49 2014 Independent Director

Juergen Riedl

43 2018 Director

Stefan Wolf

55 2018 Director

Biographies

Name Description

Soren Mellstig

Mr. Soren Mellstig has been Independent Chairman of the Board at CellaVision AB since May 4, 2016. He holds Master of Business Administration degree. He is Chairman of Ellevio AB (publ), Humana AB (publ), Impilo Holding AB and Rkliniken AB, as well as ordinary member of the Christmas Foundation. He previously held management positions at Akzo Nobel, and served as CFO and Vice President of Incentive, CFO, President and finally President and CEO of Gambro 2000-2006.

Zlatko Rihter

Mr. Zlatko Rihter has been President and Chief Executive Officer of CellaVision AB since January 1, 2015. He has held various managing positions within business development, sales, marketing, research and IT. He has over 20 years of experience from the medtech industry. He most recently worked for Origio A/S as Executive Vice President and was responsible for global sales and marketing. He also worked for ArjoHuntleigh (Getinge) and Gambro, where he was President for EMEA Sales (2012-2013), among others. He is Member of the Board of ETAC AB and Malmo FF. He holds Master of Science degree in Mechanical Engineering from Lunds Tekniska Hogskola (part of Lunds Universitet) and studied Economics at Lunds Universitet.

Magnus Blixt

Mr. Magnus Blixt has served as Chief Financial Officer of CellaVision AB since May 2, 2013. He holds Master of Science degree in Finance. He has experience of developing small and medium sized companies focusing on business performance and process improvements, within the SKF Group and Rotaform AB, among others. He most recently held the position as Business Demand Manager at SKF AB.

Mattias Lundin

Mr. Mattias Lundin has been Vice President Global Sales at CellaVision AB since 2015. He has many years of experience from the medtech industry, holding leading positions in sales and marketing. His most recent position was as VP Commercial for international and mature markets at ArjoHuntleigh, a company within Getinge group. He holds a diploma in Business Administration & Marketing Management.

Peter Wilson

Mr. Peter Wilson serves as Vice President Global Marketing at CellaVision AB. He previously served as Head of CellaVision’s subsidiary in North America from 2012 till 2014. He has been employed by the Company from 2000. He has many years of experience from global launching of new technologies and new products. He previously worked for Foss, among others. He holds a Master of Science degree in Chemistry.

Maria Morin

Ms. Maria Morin serves as Vice President Human Resources & Corporate Communications at CellaVision AB. She holds a Bachelor of Science degree in Human Resources and a Bachelor of Science degree in Economics and Business Administration. She has been employed at the Company since 2009. She has experience from various positions and companies within the field of human resources. Her most recent position was at Gambro AB. She is Member of the Board of Phase Holographic Imaging PHI AB.

Magnus Johnsson

Mr. Magnus Johnsson has been Vice President Quality at CellaVision AB since 2016. He previously was employed at the Company from 2000 till 2008. He has more than 15 years experience in med. tech industry from companies such as ArjoHuntleigh and Xellia Pharmaceuticals. His most recent position was at Xellia Pharmaceuticals. He holds M.Sc. Chemistry, B Sc. Information Systems degrees.

Magnus Lindeberg

Mr. Magnus Lindeberg has been Vice President Supply & Sourcing at CellaVision AB since 2016. He has more than 17 years experience in the medical device industry in various senior positions in the supply chain and production included Gambro. He comes from a position as Manager Materials Supply Baxter (formerly Gambro AB). He holds a M.Sc. in Mechanical Engineering.

Adam Morell

Mr. Adam Morell has been Vice President Innovation & Engineering at CellaVision AB since 2015. He previously served as Development Manager at CellaVision AB until 2011. He was employed by the Company from 2001 to 2003 and then from 2006. He also served at Agellis Group AB. He has expertise in the field of digital imaging and has been a co-inventor on several patents. He holds a Master of Science Degree in Engineering Physics, a Licentiate of Engineering in Mathematics and a Bachelor of Science degree in Medicine.

Jeppe Brandstrup

Mr. Jeppe Brandstrup has been Vice President Business Development at CellaVision AB since 2016. He has many years of experience in business development and acquisitions in the life sciences. He most recently served as Senior Acquisition Manager at Novozymes in Copenhagen. He holds M.Sc. in Finance degree.

Christer Fahraeus

Mr. Christer Fahraeus has been Member of the Board of Directors of CellaVision AB since June 1998. Previously he was Chief Executive Officer and Member of the Board of the Company. He joined the Board in 1994. He is founder of the Company. His former positions include Chief Executive Officer of Anoto Group AB and Agellis Group AB. He is founder of Anoto Group AB, Precise Biometrics AB, Agellis Group AB and Flatfrog Laboratories AB, among others. He is Chief Executive Officer/President of EQL Pharma AB and Chairman of the Board of Longboat Laboratories AB, Respiratorius AB, Umansense AB and Flatfrog Laboratories AB. He is also Member of the Boards of EQL Pharma AB, LU Holding AB and Reccan AB. Mr. Fahraeus holds a Bachelor of Science in Medicine, Master of Science degree in Bioengineering and a Bachelor of Science degree in Mathematics from Lunds Universitet. He also holds a honoris causa Doctorate in Philosophy in Engineering from Lunds Universitet and a Doctorate of Philosophy in Neurophyiology.

Asa Hedin

Ms. Asa Hedin has been Independent Director at CellaVision AB since May 6, 2015. She is also Member of the Board of Nolato AB, Industrifonden AB, Crad AB and Tobii AB. She previously held leading positions at Elekta AB being responsible for strategy, marketing and training, moreover leading positions at Siemens Healthcare and Gambro. She holds Master of Science in Biophysics.

Anna Malm Bernsten

Ms. Anna Malm Bernsten has served as Independent Member of the Board of Directors of CellaVision AB since April 29, 2010. She is Chief Executive Officer of Bernsten Konsult AB. She is Chairman of the Board of Medivir AB and Bjorn Axen AB, as well as Member of the Board of Pagengruppen AB, Probi AB, Moberg Pharma AB and BioLamina AB. She was Chairman of the Board of Oatly AB during 2016. Her former positions include Chief Executive Officer and President of Carmeda AB and management positions at Pharmacia & Upjohn and GE Healthcare Life Sciences. She holds a Master of Science degree in Chemical Engineering.

Niklas Prager

Mr. Niklas Prager has been Independent Member of the Board of Directors of CellaVision AB since May 7, 2014. He was President and CEO of Medivir AB during 2016. His former positions include CEO of Envirotainer AB, Qbtech AB and Pfizer AB. He is Member of the Board of Adero AB and Chairman of the Board of Fodi Skandinavien AB, Qbtech AB. He holds Master of Business Administration degree.

Juergen Riedl

Mr. Juergen Riedl has been Independent Director of CellaVision AB since May 4, 2018. Juergen has a background in clinical laboratory work and is an internationally recognized expert in hematology. He has experience from several senior positions at Albert Schweitzer Hospital in Dordrecht, Beatrix Hospital in Gorinchem and Ikazia Hospital in Rotterdam in clinical chemistry and hematology. He holds Post-doc & PhD degrees.

Stefan Wolf

Mr. Stefan Wolf has been Independent Director of CellaVision AB since May 4, 2018. He is also Division President of Immune Diagnostic Division at Thermo Fisher Scientific. Before that he has been CEO of Hemostasis, Hematology and Specialty Diagnostics at Siemens Healthineers. He is educated Biological Laboratory Technician & Sales Specialist.